Federal funding for HIV/AIDS in jeopardy?

Article Abstract:

Legislators trying to remove $1.3 trillion from the federal budget may cut spending for treatment and prevention of HIV and AIDS. Predictions of a 20% decline in new cases partly result from changes in statistical methodology used by the Centers for Disease Control & Prevention. As illustrated by the resurgence of tuberculosis after it seemed to have disappeared, slashing funds for treatment and control of HIV/AIDS may prove to be dangerous.

Research and Development in the Physical, Engineering, and Life Sciences, Research and Testing Services, Medical Research, Centers for Disease Control, Care and treatment, Finance, HIV (Viruses), HIV, AIDS (Disease), United States. Centers for Disease Control and Prevention

---

Agency shifts focus of guidelines work to research

Article Abstract:

The Agency for Health Care Policy and Research (AHCPR) has changed its position on developing medical research guidelines and is implementing an "Evidence-Based Practice Program," which will include reports from research centers on existing data for medical topics. The AHCPR also plans an all-inclusive national guidelines clearinghouse, and is soliciting support from other national health groups to that end.

Professional Organizations, Medical Associations, Standards, Social policy, Medical societies, United States. Agency for Healthcare Research and Quality

---

Similar abstracts:

• Abstracts: Putting ageism in the past. Agencies offer freedom to choose
• Abstracts: Recognising wound infection. The impact of environmental cleanliness on infection rates. Examining the literature on using tap water in wound cleaning
• Abstracts: Obstacles seen in physician use of guidelines. Association stands firm in opposition to suicide
• Abstracts: Formulary fundamentals: ethical rules a must when limits put on what can be prescribed
• Abstracts: Commitment to quality starts with measuring performance. Sex turns dangerous

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.